EUVIMEDEUVIMED entdecken
Open Access

Real-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters

Hiroya Kitsunai, Fumika Maruyama, Yukie Miyano, Tomoe Abe, Hiroyoshi Kurihara, Ken Tsuji, Atsuko Abiko, Yoshihiro Miyamoto, Reiko Homma, Akinobu Nakamura, Hiroshi Nomoto, Hokkaido-TZP Study Group

Endocrine Journal · 2026 · 73 (11) · 1261-1269

DOI: 10.1507/endocrj.ej26-0246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Journal, 2026. Verfasst von Hiroya Kitsunai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Metabolism, and Rheumatology, Department of Internal Medicine, Asahikawa Medical University, Hokkaido 078-8510, Japan. Hauptthemen laut MEDLINE: Tirzepatide, Diabetes Mellitus, Type 2, Hypoglycemia, Weight Loss. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TirzepatideDiabetes Mellitus, Type 2HypoglycemiaWeight LossHypoglycemic AgentsHumansAgedFemaleMaleGlycated HemoglobinTreatment OutcomeAged, 80 and overBody Mass IndexBlood Glucose

Stichwörter der Autor:innen

Hypoglycemia riskOlder patientReal-world clinical evidenceTirzepatideType 2 diabetes

Substanzen

TirzepatideHypoglycemic AgentsGlycated Hemoglobinhemoglobin A1c protein, humanBlood Glucose

Autor:innen und Institutionen

  • Division of Endocrinology, Metabolism, and Rheumatology, Department of Internal Medicine, Asahikawa Medical University, Hokkaido 078-8510, Japan.
  • Sapporo Diabetes and Thyroid Clinic, Hokkaido 060-0807, Japan.
  • Kurihara Clinic, Hokkaido 004-0053, Japan.
  • Department of Diabetology and Endocrinology, Japanese Red Cross Asahikawa Hospital, Hokkaido 070-0061, Japan.
  • Department of Diabetology and Endocrinology, Asahikawa City Hospital, Hokkaido 070-8610, Japan.
  • Department of Metabolism and Endocrinology, Asahikawa-Kosei General Hospital, Hokkaido 078-8211, Japan.

Zitieren

APA

Kitsunai, H., Maruyama, F., Miyano, Y., Abe, T., Kurihara, H., Tsuji, K., Abiko, A., Miyamoto, Y., Homma, R., Nakamura, A., Nomoto, H., & Hokkaido-TZP Study Group (2026). Real-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters. Endocrine Journal, 73(11), 1261-1269. https://doi.org/10.1507/endocrj.ej26-0246

Vancouver

Kitsunai H, Maruyama F, Miyano Y, Abe T, Kurihara H, Tsuji K, et al. Real-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters. Endocrine Journal. 2026;73(11):1261-1269. doi:10.1507/endocrj.ej26-0246

BibTeX
@article{Kitsunai2026,
  author = {Kitsunai, Hiroya and Maruyama, Fumika and Miyano, Yukie and Abe, Tomoe and Kurihara, Hiroyoshi and Tsuji, Ken and Abiko, Atsuko and Miyamoto, Yoshihiro and Homma, Reiko and Nakamura, Akinobu and Nomoto, Hiroshi and Hokkaido-TZP Study Group, Hokkaido-TZP Study Group},
  title = {Real-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters},
  journal = {Endocrine Journal},
  year = {2026},
  volume = {73},
  number = {11},
  pages = {1261--1269},
  doi = {10.1507/endocrj.ej26-0246}
}
Kostenlos starten →